Publication Cover
Victims & Offenders
An International Journal of Evidence-based Research, Policy, and Practice
Volume 13, 2018 - Issue 2
506
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Occupational Pharmaceutical Counterfeiting Schemes: A Crime Scripts Analysis

, &

References

  • Albanese, J. S. (2011). Transnational crime and the 21st century: Criminal enterprises, corruption, and opportunity. New York, NY: Oxford University Press.
  • Amico, K., Aaronson, E., & Zucker, H. (2015). Innovations to address global drug counterfeiting: Implications for urbanization and health. In R. Ahn, T. F. Burke, & A. M. McGahan (Eds.), Innovating for healthy urbanization (141–163). New York, NY: Springer.
  • Attaran, A., Bate, R., & Kendall, M. (2011). Why and how to make an international crime of medicine counterfeiting. Journal of International Criminal Justice, 9(2), 325–354. doi:10.1093/jicj/mqr005
  • Beauregard, E., Proulx, J., Rossmo, K., Leclerc, B., & Allaire, J. F. (2007). Script analysis of the hunting process of serial sex offenders. Criminal Justice and Behavior, 34(8), 1069–1084. doi:10.1177/0093854807300851
  • Benjaminson, W. (2005, October 27). Exxon-Mobil employees got fake flu shots, authorities say. Associated Press. Retrieved from http://www.myplainview.com/news/article/Exxon-Mobil-employees-got-fake-flu-shots-8564011.php.
  • Borrion, H. (2013). Quality assurance in crime scripting. Crime Science, 2(6), 1–12. doi:10.1186/2193-7680-2-6
  • Bova, C., Route, P. S., Fennie, K., Ettinger, W., Manchester, G. W., & Weinstein, B. (2012). Measuring patient-provider trust in a primary care population: Refinement of the health care relationship trust scale. Research in Nursing and Health, 35(4), 397–408. doi:10.1002/nur.21484
  • Brayley, H., Cockbain, E., & Laycock, G. (2011). The value of crime scripting: Deconstructing internal child sex trafficking. Policing, 5(2), 132–143. doi:10.1093/police/par024
  • Bunker, A. M. (2007). Deadly dose: Counterfeit pharmaceuticals, intellectual property and human health. Journal of the Patent and Trademark Office Society, 89(6), 493–887.
  • Catizone, C. (2006). Counterfeit drugs and states’ efforts to combat the problem. Journal of Pharmacy Practice, 19(3), 165–170. doi:10.1177/0897190006292948
  • Caudron, J. M., Ford, N., Henkens, M., Mace, C., Kiddle‐Monroe, R., & Pinel, J. (2008). Substandard medicines in resource‐poor settings: A problem that can no longer be ignored. Tropical Medicine & International Health, 13(8), 1062–1072. doi:10.1111/j.1365-3156.2008.02106.x
  • Choi, S. H., Yang, B., Cheung, H. H., & Yang, Y. X. (2015). RFID tag data processing in manufacturing for track-and-trace anti-counterfeiting. Computers in Industry, 68, 148–161. doi:10.1016/j.compind.2015.01.004
  • Clarke, R. V., & Cornish, D. B. (1985). Modeling offenders’ decisions: A framework for research and policy. Crime and Justice, 6, 147–185. doi:10.1086/449106
  • Cockburn, R., Newton, P. N., Agyarko, E. K., Akunyili, D., & White, N. J. (2005). The global threat of counterfeit drugs: Why industry and governments must communicate the dangers. Plos Medicine, 2(4), e100. doi:10.1371/journal.pmed.0020100
  • Connelly, R. (2010, April 16). Fake-Botox doctor gets some prison time. Houston Press. Retrieved from http://www.houstonpress.com/news/fake-botox-doctor-gets-some-prison-time-6742461.
  • Cooper, H. (2003). In the case of the diluting druggist, no good deed goes unpunished. Mississippi Link, 11(5), 8.
  • Cornish, D. B. (1994). The procedural analysis of offending and its relevance for situation prevention. In R. V. Clarke (Ed.), Crime prevention studies (Vol. 3, pp. 151–196). Monsey, NY: Criminal Justice Press.
  • Cox, A. A. (2010). Edwardsville pharmacist and the Medicine Shoppe of Edwardsville plead guilty to misbranding of a drug in federal court. Office of the United States Attorney Southern District of Illinois. Retrieved from http://www.justice.gov/usao/ils/press/2010/Jan/01152010_Thalmann_press%20release.htm.
  • Deisingh, A. K. (2005). Pharmaceutical counterfeiting. The Analyst, 130(3), 271–279. doi:10.1039/b407759h
  • Drug Quality and Security Act of 2013, 21 U.S.C. § 503A.
  • Forzley, M. (2003). Counterfeit goods and the public’s health and safety. Washington, DC: International Intellectual Property Institute.
  • Gaudiano, M. C., Antoniella, E., Bertocchi, P., & Valvo, L. (2006). Development and validation of a reversed-phase LC method for analyzing potentially counterfeit antimalarial medicines. Journal of Pharmaceutical and Biomedical Analysis, 42(1), 132–135. doi:10.1016/j.jpba.2006.01.059
  • Glaser, B. G., & Strauss, A. (1967). The discovery of grounded theory: Strategies for qualitative research. Chicago, IL: Aldine-Athestor.
  • Heinonen, J. A., & Wilson, J. M. (2012). Product counterfeiting at the state level: An empirical examination of Michigan-related incidents. International Journal of Comparative and Applied Criminal Justice, 36(4), 273–290. doi:10.1080/01924036.2012.721198
  • Hollis, M., & Wilson, J. M. (2014). Who are the guardians in product counterfeiting: A theoretical application of routine activities theory. Crime Prevention and Community Safety, 16(3), 169–188. doi:10.1057/cpcs.2014.6
  • Hosseini, S. A. R., Darbooy, S., Tehrani Banihasemi, S. A., Naseri, S. M., & Dinarvand, R. (2011). Counterfeit medicines: Report of a cross-sectional retrospective study in Iran. Public Health, 125(3), 165–171. doi:10.1016/j.puhe.2010.11.015
  • Huh, J., Delorme, D. E., & Reid, L. N. (2016). A model of consumer response to over-the-counter drug advertising: Antecedents and influencing factors. Journal of Health Communication, 21(1), 109–117. doi:10.1080/10810730.2015.1033116
  • Jones, D. E., Carson, K. A., Bleich, S. N., & Cooper, L. A. (2012). Patient trust in physicians and adoption of lifestyle behaviors to control high blood pressure. Patient Education and Counseling, 89(1), 57–62. doi:10.1016/j.pec.2012.06.003
  • Jones, E. C., Gupta, S., & Starr, L. (2015). RFID implementation and enterprise management in the healthcare sector. International Journal of Supply Chain Management, 4(3), 78–86.
  • Kelesidis, T., Kelesidis, I., Rafailidis, P. I., & Falagas, M. E. (2007). Counterfeit or substandard antimicrobial drugs: A review of the scientific evidence. Journal of Antimicrobial Chemotherapy, 60(2), 214–236. doi:10.1093/jac/dkm109
  • Koku, P. S. (2016). Overpromotion and the learned intermediary doctrine in advertising of medicine and medical devices in the United States. In M. D. Groza & C. B. Ragland (Eds.), Marketing challenges in a turbulent business environment (pp. 711–713). New York, NY: Springer.
  • Lavorgna, A. (2015). The online trade in counterfeit pharmaceuticals: New criminal opportunities, trends and challenges. European Journal of Criminology, 205(12), 226–241. doi:10.1177/1477370814554722
  • MacDougall, E. D. (1933). A symposium on mercenary crime. Boston, MA: The Stratford Company.
  • Miles, M. B., & Hubberman, A. M. (1994). An expanded sourcebook: Qualitative data analysis (2nd ed.). Thousand Oaks, CA: Sage.
  • National Post (2003, September 23). Doctor admits diluting cancer drug for profit. National Post. Pg. A8.
  • Newton, P. N., Green, M. D., & Fernández, F. M. (2010). Impact of poor-quality medicines in the “developing” world. Trends in Pharmacological Sciences, 31(3), 99–101. doi:10.1016/j.tips.2009.11.005
  • Peek, M. E., Gorawara-Bhat, R., Quinn, M. T., Odoms-Young, A., Wilson, S. C., & Chin, M. H. (2013). Patient trust in physicians and shared decision-making among African-Americans with diabetes. Health Communication, 28(6), 616–623. doi:10.1080/10410236.2012.710873
  • Qureshi, Z. P., Norris, L., Sartor, O., McKoy, J. M., Armstrong, J., Raisch, D. W., … Bennett, C. L. (2011). Caveat oncologist: Clinical findings and consequences of distributing counterfeit erythropoietin in the United States. Journal of Oncology Practice, 8(2), 84–90. doi:10.1200/JOP.2011.000325
  • Rierson, S. L. (2008). Pharmaceutical counterfeiting and the puzzle of remedies. Wake Forest Intellectual Property Law Journal, 8, 433–433.
  • Saldaña, J. (2011). Fundamentals of qualitative research. New York, NY: Oxford University Press.
  • Tompson, L., & Chainey, S. (2011). Profiling illegal waste activity: Using crime scripts as a data collection and analytical strategy. European Journal on Criminal Policy and Research, 17(3), 179–201. doi:10.1007/s10610-011-9146-y
  • Trademark Counterfeiting Act of 1984, 18 U.S.C. § 2320.
  • Trademark Dilution Revision Act of 2006, 15 U.S.C. § 1051
  • Tremblay, P., Talon, B., & Hurley, D. (2001). Body switching and related adaptations in the resale of stolen vehicles: Script elaborations and aggregate crime learning curves. British Journal of Criminology, 41(4), 561–579. doi:10.1093/bjc/41.4.561
  • United States vs. Wallace E. Gonsalves, 1st U.S. Circuit Court of Appeals (2006).
  • Veronin, M. A., & Youan, B. B. (2004). Medicine—Magic bullet gone astray: Medications and the Internet. Science, 305(5683), 481–481. doi:10.1126/science.1097355
  • World Health Organization. (2006). Counterfeit medicines: The silent epidemic. Retrieved from http://www.who.int/mediacentre/news/releases/2006/pr09/en/
  • Yar, M. (2008). The other global drugs crisis: Assessing the scope, impacts and drivers of the trade in dangerous counterfeit pharmaceuticals. International Journal of Social Inquiry, 1(1), 151–166.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.